NCT07532525 2026-04-16Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or LymphomaUniversity of Michigan Rogel Cancer CenterPhase 1 Not yet recruiting12 enrolled